Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. v. Ascent Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited
This text of Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. v. Ascent Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited (Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. v. Ascent Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
ASTELLAS PHARMA INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC., 1:23CV00486
Plaintiffs, MEMORANDUM AND ORDER vs.
ASCENT PHARMACEUTICALS, INC., MSN PHARMACEUTICALS INC. and MSN LABORATORIES PRIVATE LIMITED
Defendants.
This matter is before the Court on the Report and Recommendation (“R&R”) regarding Plaintiffs’ motion to dismiss defendants’ counterclaims of inequitable conduct and to strike the related affirmative defenses, issued by Magistrate Judge Eleanor G. Tennyson. D.I. 293, see D.I. 227. Defendant Ascent Pharmaceutical, Inc. (“Defendant” or “Ascent”) has objected to the R&R, D.I. 297, and Plaintiffs Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. (collectively, “Plaintiffs” or “Astellas”) responded to the objections, D.I. 317. The Court adopts the magistrate judge’s R&R in full, overrules Defendant’s objections, and grants-in-part and denies-in-part Plaintiffs’ motion to dismiss Defendant’s counterclaims of inequitable conduct and to strike the related affirmative defenses. I. STANDARD OF REVIEW A district court may modify or set aside any part of a magistrate judge’s order that is “clearly erroneous or contrary to law.” 28 U.S.C. § 636(b)(1)(A); Fed. R. Civ. P. 72(a). The district court “shall make a de novo determination of those portions of the report or specified proposed findings or recommendations to which objection is made” and “may accept, reject, or modify, in whole or in part, the findings or recommendations made by the magistrate judge.” 28 U.S.C. § 636(b)(1)(C); see also Fed. R. Civ. P. 72(b). The Supreme Court has construed the statutory grant of authority conferred on magistrate judges under 28 U.S.C. § 636 to mean that nondispositive pretrial matters are
governed by § 636(b)(1)(A) and dispositive matters are covered by § 636(b)(1)(B). Gomez v. United States, 490 U.S. 858, 873–74 (1989); see also Fed. R. Civ. P. 72(a). Under subparagraph (b)(1)(B), a district court may refer a dispositive motion to a magistrate judge “to conduct hearings, including evidentiary hearings, and to submit to a judge of the court proposed findings of fact and recommendations for the disposition.” 28 U.S.C. § 636(b)(1)(B); see Equal Emp. Opportunity Comm'n v. City of Long Branch, 866 F.3d 93, 99–100 (3d Cir. 2017). The product of a magistrate judge, following a referral of a dispositive matter, is often called a “report and recommendation” (“R&R”). See Equal Employment Opportunity Commission, 866 F.3d at 99–100. “Parties ‘may serve and file
specific written objections to the proposed findings and recommendations . . ..’” Id. at 99 (quoting Fed. R. Civ. P. 72(b)(2)). “If a party objects timely to a magistrate judge’s report and recommendation, the district court must ‘make a de novo determination of those portions of the report or specified proposed findings or recommendations to which objection is made.’” Id. (quoting 28 U.S.C. § 636(b)(1)). II. DISCUSSION The Court has reviewed the R&R, Defendant’s objection and appeal regarding the report and recommendation, and Plaintiffs’ response to Defendant’s objections to the R&R. After thorough consideration, the Court affirms the magistrate judge’s well- reasoned R&R for the reasons stated therein. III. CONCLUSION The Court finds the magistrate judge is correct in all respects and adopts the Report and Recommendation, D.I. 293, in its entirety.
THEREFORE, IT IS ORDERED: 1. Defendant’s objections, D.I. 297, are overruled; 2. The Court adopts magistrate judge’s Report and Recommendation, D.I. 293, in its entirety; and 3. Plaintiffs’ motion to dismiss Defendant’s counterclaims of inequitable conduct and to strike the related affirmative defenses, D.I. 227, is granted-in-part and denied-in-part as set forth in the Report and Recommendation, D.I. 293.
Dated this 16th day of October, 2025.
BY THE COURT:
s/ Joseph F. Bataillon Senior United States District Judge
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. v. Ascent Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited, Counsel Stack Legal Research, https://law.counselstack.com/opinion/astellas-pharma-inc-astellas-ireland-co-ltd-and-astellas-pharma-global-ded-2025.